Lieff Cabraser Civil Justice Blog

Sarah London Discusses Zofran Anti-Nausea Medication Birth Defect Injury Lawsuits

Sarah London Discusses Dangerous Birth Defects from Zofran (ondansetron) Use

Parents charge that Zofran (generic name ondansetron) is a dangerous and defective drug because its use by pregnant women can lead to serious birth defects. Zofran was approved by the FDA in 1991 to treat extreme nausea from chemotherapy and later expanded for use as a treatment for serious surgical nausea. Lawsuits allege that the drug has been marketed off-label by GlaxoSmithKline to obstetricians and gynecologists to prescribe to their pregnant patients to control the pregnancy nausea commonly referred to as “morning sickness.”

Lieff Cabraser attorney Sarah London has produced this video summarizing evidence that links Zofran taken during pregnancy with increased risks of certain birth defects including cleft palates, certain heart and kidney defects, and other injuries.

Sarah London on Dangerous Zofran Birth Defect Injuries and Lawsuits

Zofran lawsuits allege that the drug can lead to serious birth defects when taken by pregnant women.